What are the risks of lacosamide during pregnancy?

How does lacosamide affect fetal development?

Lacosamide crosses the placenta and limited human data suggest a possible increase in major congenital malformations, particularly cardiac and skeletal defects. Animal studies showed embryo-fetal toxicity at clinically relevant doses, raising concern even though human evidence remains sparse.

What birth defects have been reported with lacosamide exposure?

Case reports and small registries list heart malformations such as ventricular septal defects, skeletal anomalies including limb reductions, and neural tube defects. Absolute risk numbers are not firmly established because sample sizes in published cohorts stay small.

Can lacosamide be used in the first trimester safely?

Most structural malformations occur during organogenesis, so first-trimester exposure carries the highest theoretical risk. Some clinicians continue lacosamide when seizure control is critical, but they counsel patients on the uncertain safety profile and often recommend enhanced prenatal screening.

What happens if a woman becomes pregnant while taking lacosamide?

Continuation decisions hinge on seizure frequency and type. Abrupt discontinuation can provoke uncontrolled seizures, which also endanger mother and fetus. Guidelines therefore stress individualized risk-benefit assessment, often involving neurology and maternal-fetal medicine specialists.

How is lacosamide exposure monitored during pregnancy?

Prenatal care typically includes detailed anatomic ultrasound at 18–22 weeks, fetal echocardiography if indicated, and enrollment in a pregnancy registry such as the North American AED Pregnancy Registry. Postnatal pediatric evaluation checks for developmental delays.

Does lacosamide pass into breast milk, and what are the infant risks?

Lacosamide is excreted in breast milk at low levels. Observed infant effects have been limited to mild sedation or feeding difficulties in case reports. Many mothers continue breastfeeding with monitoring of the infant for drowsiness or poor weight gain.

What alternatives exist if lacosamide is stopped during pregnancy?

Switching to lamotrigine or levetiracetam is common when seizure type allows, because larger pregnancy registries show lower malformation rates with those agents. Dose adjustments and therapeutic drug monitoring help maintain seizure control during pharmacokinetic changes of pregnancy.

When do lacosamide patents expire, and will generics affect access?

The key U.S. composition-of-matter patent expires in 2022, yet pediatric exclusivity and other protections extend market exclusivity into 2025. DrugPatentWatch.com tracks remaining patents and Paragraph IV challenges that could bring lower-cost generics sooner.